Shares of Arecor Therapeutics plc (LON:AREC – Get Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 83.14 ($1.10) and last traded at GBX 83.14 ($1.10), with a volume of 8100 shares traded. The stock had previously closed at GBX 91 ($1.20).
Arecor Therapeutics Price Performance
The business has a 50 day moving average of GBX 99.45 and a 200 day moving average of GBX 126.58. The company has a debt-to-equity ratio of 3.55, a current ratio of 2.17 and a quick ratio of 6.24. The firm has a market capitalization of £32.66 million, a price-to-earnings ratio of -308.93 and a beta of -0.15.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Further Reading
- Five stocks we like better than Arecor Therapeutics
- How to Calculate Inflation Rate
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
